Exelixis
EXEL
#1557
Rank
โ‚ฌ12.36 B
Marketcap
49,90ย โ‚ฌ
Share price
-1.95%
Change (1 day)
48.77%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company